Tracsis PLC
XBER:4T2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Tracsis PLC
XBER:4T2
|
UK |
|
Nektar Therapeutics
F:ITH0
|
US |
|
Regulus Therapeutics Inc
F:7RG0
|
US |
|
E
|
Eurocash SA
SWB:E07
|
PL |
|
T
|
Tekcapital PLC
OTC:TEKCF
|
UK |
Wall St Price Targets
4T2 Price Targets Summary
Tracsis PLC
According to Wall Street analysts, the average 1-year price target for 4T2 is 5.95 EUR with a low forecast of 5.29 EUR and a high forecast of 7.26 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 4T2's stock price target?
Price Target
5.95
EUR
According to Wall Street analysts, the average 1-year price target for 4T2 is 5.95 EUR with a low forecast of 5.29 EUR and a high forecast of 7.26 EUR.
What is the Revenue forecast for Tracsis PLC?
Projected CAGR
1%
Over the last 13 years, the compound annual growth rate for Revenue has been 19%. The projected CAGR for the next 3 years is 1%.
What is the Gross Profit forecast for Tracsis PLC?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 16%. The projected CAGR for the next 3 years is 4%.
What is the Operating Income forecast for Tracsis PLC?
Projected CAGR
55%
Over the last 13 years, the compound annual growth rate for Operating Income has been 1%. The projected CAGR for the next 3 years is 55%.
What is the Pre-Tax Income forecast for Tracsis PLC?
Projected CAGR
101%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -5%. The projected CAGR for the next 3 years is 101%.
What is the Net Income forecast for Tracsis PLC?
Projected CAGR
167%
Over the last 13 years, the compound annual growth rate for Net Income has been -11%. The projected CAGR for the next 3 years is 167%.
